SearchBox:

Search Term: " salva "

  Messages 1-5 from 5 matching the search criteria.
The Ultimate Guide to Cellular Longevity: NAD+, Methylation, and Senolytics Darrell Miller 9/10/26
Is NAD+ the "Missing Link" in Modern Longevity Science? Darrell Miller 4/11/26
How calcium can Help Prevent Bone Loss Darrell Miller 11/8/13
D-Ribose Powder Benefits! Darrell Miller 4/10/07
NOW is the leader in quality and value Darrell Miller 10/21/05



AURA CACIA Essential Oil Clary Sage (salva sclarea)
   .5 fl oz $15.09 34% OFF $ 9.96

The Ultimate Guide to Cellular Longevity: NAD+, Methylation, and Senolytics
TopPreviousNext

Date: September 10, 2026 10:57 AM
Author: Darrell Miller (support@vitanetonline.com)
Subject: The Ultimate Guide to Cellular Longevity: NAD+, Methylation, and Senolytics


Introduction: Understanding Cellular Aging and Energy Decline

Biological aging represents a progressive decline in cellular maintenance, structural repair, and energy generation. Over decades, tissues experience an attrition of functional reserves, compromised stress resilience, and persistent low-grade systemic inflammation. At the cellular scale, biological degeneration is driven by a failure to generate bioenergetic fuel, repair genetic code, and clear metabolic waste.

Cellular aging is characterized by interconnected biological disruptions known as the hallmarks of aging. These encompass genomic instability, epigenetic alterations, mitochondrial decay, loss of proteostasis, and cellular senescence. Rather than operating as isolated occurrences, these phenomena establish a self-reinforcing degenerative cycle: declining cellular power generation impairs enzymatic genetic repair, promoting the accumulation of damaged cells that enter irreversible growth arrest and poison surrounding healthy tissues. Mitigating cellular aging requires examining how microscopic bioenergetic pathways deteriorate and evaluating how targeted nutritional and biochemical interventions can restore cellular homeostasis.

The Role of Mitochondria and ATP Production

Every biological function - from muscular contraction to continuous DNA replication - depends on adenosine triphosphate (ATP), the primary biochemical energy currency of living systems. Cells produce the vast majority of this energy within mitochondria through oxidative phosphorylation. Within these specialized organelles, metabolic intermediates derived from dietary carbohydrates and lipids donate high-energy electrons to the electron transport chain. The flow of these electrons across protein complexes establishes an electrochemical proton gradient across the inner mitochondrial membrane, driving ATP synthase to manufacture ATP.

A youthful cell functions like an efficient municipal power grid, dynamically matching energetic demands with immediate ATP output. However, as biological aging progresses, mitochondrial efficiency declines. The electron transport chain becomes structurally leaky, inadvertently shedding electrons that react with ambient molecular oxygen to produce reactive oxygen species (ROS). While regulated levels of ROS participate in vital intracellular signaling, chronic excess induces widespread oxidative stress.

Mitochondria are exceptionally vulnerable to this oxidative burden because they carry their own circular genetic material, known as mitochondrial DNA (mtDNA). Unlike nuclear DNA, mtDNA lacks the protective shielding of histone proteins and possesses rudimentary repair systems. As a result, mtDNA sustains cumulative oxidative damage, encoding increasingly defective electron transport chain proteins. This dynamic generates a bioenergetic deficit: degraded mitochondria synthesize progressively less ATP while emitting greater volumes of damaging free radicals. Deprived of optimal ATP reserves, cells lack the energy necessary to drive vital enzymatic repair cascades, accelerating structural degeneration and functional exhaustion.

How Cellular Senescence Accelerates the Aging Process

When healthy cells confront critical physiological damage - such as severe telomere attrition, persistent DNA double-strand breaks, or oxidative stress - they activate protective cell cycle arrest pathways governed primarily by the p53/p21^CIP1 and p16^INK4a/Rb molecular checkpoints. This defensive shutdown, termed cellular senescence, permanently prevents the replication of potentially premalignant or mutated cells.

Senescent cells, colloquially known as "zombie cells," enter a state of permanent growth arrest while actively resisting programmed cell death (apoptosis). Over time, these cells accumulate within adipose depots, skeletal muscle, the vascular endothelium, and major organs, largely because immune surveillance and clearance pathways simultaneously lose functional efficiency.

The systemic danger of senescent cells stems from their secretome. Rather than remaining biologically inert, senescent cells develop a hyperactive secretory state termed the Senescence-Associated Secretory Phenotype (SASP). The SASP is a destructive mixture of pro-inflammatory cytokines, chemokines, extracellular matrix-degrading matrix metalloproteinases (MMPs), and reactive oxygen species.

Through this toxic secretome, even a small burden of senescent cells can impair whole-tissue architecture. SASP factors degrade surrounding structural proteins, induce insulin resistance in neighboring metabolic cells, and biochemically force adjacent healthy cells into secondary senescence. This persistent paracrine signaling fuels chronic, sterile, low-grade systemic inflammation, termed "inflammaging," which accelerates systemic tissue degeneration and elevates susceptibility to degenerative age-related pathologies.

Nicotinamide Riboside (NR) and the NAD+ salvage Pathway

The Biochemistry of NAD+ Depletion Over Time

Nicotinamide adenine dinucleotide (NAD+) is an indispensable coenzyme present in every living cell. NAD+ fulfills a dual biological mandate: it serves as a central redox cofactor that shuttles electrons between cellular metabolic reactions, and it functions as an obligatory consumable substrate for regulatory enzymes that preserve cellular viability. In its redox capacity, NAD+ accepts electrons to form NADH during glycolysis, the tricarboxylic acid (TCA) cycle, and fatty acid beta-oxidation, subsequently donating those electrons to Complex I of the respiratory chain to power ATP synthesis.
NAD+ Pathway / Consumer Primary Biochemical Role Functional Impact of Age-Related Depletion
Mitochondrial Redox Reactions Shuttles electrons (NAD+ <--> NADH) to drive oxidative phosphorylation. Impaired ATP generation, diminished metabolic flexibility.
Sirtuin Enzymes (SIRT1-7) Removes acetyl groups from regulatory proteins; coordinates longevity defense. Blunted mitochondrial biogenesis, degraded metabolic regulation.
PARP Enzymes (PARP-1) Detects DNA strand breaks and synthesizes poly(ADP-ribose) scaffolds. Hyperactivation drains systemic NAD+ pools during genotoxic stress.
CD38 Ecto-Enzyme Glycohydrolase that consumes cellular NAD+ and its precursors. Upregulated by SASP, aggressively accelerating NAD+ depletion.
Tissue concentrations of NAD+ decline with advancing chronological age. Clinical evidence shows that systemic NAD+ levels in midlife and older adults can drop by 50% to over 80% compared to young adult baselines. This deficit is driven not only by reduced biosynthesis, but by accelerating enzymatic consumption.

The primary enzymatic driver of age-related NAD+ destruction is CD38, a membrane-bound glycohydrolase expressed on immune cells that is upregulated in response to chronic SASP exposure. Concurrently, lifelong genotoxic damage causes persistent activation of Poly(ADP-ribose) polymerase 1 (PARP-1), an enzyme that cleaves the glycosidic bonds of NAD+ to assemble branched poly(ADP-ribose) chains at DNA lesion sites. Because PARP-1 consumes NAD+ without directly recycling the molecule, chronic DNA damage depletes intracellular NAD+ pools, impairing bioenergetics and limiting sirtuin activity.

How NR Efficiently Boosts Cellular NAD+ Levels

The mammalian body maintains its NAD+ supply through three distinct biosynthetic routes: the de novo pathway from dietary L-tryptophan, the Preiss-Handler pathway from nicotinic acid (niacin), and the NAD+ salvage Pathway. The de novo pathway requires substantial energy expenditure, consuming roughly sixty milligrams of dietary tryptophan to yield a single milligram of NAD+. The Preiss-Handler pathway, while effective, can induce cutaneous prostaglandin-mediated flushing at therapeutic intakes. Consequently, the salvage pathway serves as the primary mechanism for maintaining intracellular NAD+ pools.

The salvage pathway recycles the breakdown product nicotinamide (NAM), which is released whenever NAD+-consuming enzymes execute their functions. Under normal conditions, cells convert free nicotinamide into nicotinamide mononucleotide (NMN) via the rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT), after which NMN adenylyltransferases (NMNAT1–3) complete the conversion into NAD+. However, NAMPT expression declines with advancing age, chronic inflammation, and metabolic stress, limiting the recycling capacity of the cell.

Nicotinamide Riboside (NR) is a naturally occurring pyridine nucleoside that bypasses this enzymatic bottleneck. Upon cellular entry via equilibrative nucleoside transporters, NR is directly phosphorylated into NMN by nicotinamide riboside kinases (NRK1 and NRK2) using a single molecule of ATP. Because the NRK pathway remains intact and robust across the lifespan, NR provides an efficient alternative entry point into the NAD+ salvage cascade.

Clinical evaluations in humans confirm the safety, bioavailability, and pharmacokinetics of oral NR supplementation. Randomized, double-blind, placebo-controlled trials reveal that oral NR chloride produces dose-dependent increases in steady-state whole blood NAD+ concentrations. Dosing regimens of 100 mg, 300 mg, and 1,000 mg daily elevate blood NAD+ levels by approximately 22%, 51%, and up to 142%, respectively, within two weeks of administration, maintaining these elevations throughout continuous use. High-resolution metabolomic analyses also demonstrate parallel elevations in nicotinic acid adenine dinucleotide (NAAD), establishing it as a reliable biomarker of active intracellular NAD+ synthesis without hepatic or systemic toxicity.

Sirtuin Activation and DNA Repair Mechanisms

Replenishing intracellular NAD+ supports functions beyond mitochondrial ATP generation. NAD+ functions as an obligatory cofactor for sirtuins (SIRT1 through SIRT7), a family of class III histone and non-histone protein deacetylases that regulate stress resilience, metabolic homeostasis, and cell survival. Sirtuins couple the removal of acetyl groups from target lysine residues to the stoichiometric cleavage of NAD+, producing nicotinamide and O-acetyl-ADP-ribose. In states of NAD+ deficiency, sirtuin enzymes remain inactive regardless of cellular demand.

In the nucleus, SIRT1 coordinates defense against cellular decline. When activated by restored NAD+ levels, SIRT1 deacetylates peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1a), the master transcriptional coactivator of mitochondrial biogenesis. This deacetylation stimulates mitochondrial replication and assembly, expanding functional respiratory capacity. Concurrently, SIRT1 deacetylates the p65 subunit of nuclear factor-kappa B (NF-kB), suppressing the transcription of pro-inflammatory cytokines. In the mitochondria, SIRT3 utilizes NAD+ to deacetylate metabolic enzymes and superoxide dismutase 2 (SOD2), enhancing the organelle's capacity to neutralize reactive oxygen species.

At the same time, cellular NAD+ levels directly regulate genomic integrity through PARP-1. When genotoxic stress or oxidative damage induces single- or double-strand DNA breaks, PARP-1 binds to the damaged termini using its zinc-finger domains. Bound PARP-1 hydrolyzes NAD+ to synthesize extensive, negatively charged poly(ADP-ribose) polymers on itself and adjacent histones. This modification relaxes chromatin architecture and establishes an electrostatic scaffold that recruits base excision repair and homologous recombination complexes.

Recent discoveries demonstrate close crosstalk between sirtuins and PARP-1 during DNA repair. PARP-1 recruits SIRT1 to double-strand breaks, where SIRT1 deacetylates the chromatin-remodeling ATPase BRG1 to displace nucleosomes and facilitate homologous recombination. However, because PARP-1 and SIRT1 draw from the same intracellular NAD+ pool, severe NAD+ depletion forces a biological compromise: PARP-1 consumes the scarce remaining cofactor to address DNA damage, leaving sirtuins deactivated. Restoring NAD+ via NR prevents this deficit, enabling concurrent genomic repair and sirtuin-mediated metabolic defense.

Quercetin: A Powerful Senolytic and mTOR Regulator

Clearing Senescent "Zombie" Cells from Tissues

The accumulation of senescent cells has driven interest in senolytics: molecules that selectively eliminate senescent cells while sparing healthy, non-senescent populations. Senolytic agents exploit a specific vulnerability in senescent cells. Because senescent cells produce cytotoxic, pro-inflammatory SASP factors that would normally induce their own death, they become dependent on upregulated Senescent Cell Anti-Apoptotic Pathways (SCAPs) to survive. The SCAP network involves anti-apoptotic proteins (such as BCL-2 and BCL-xL), the PI3K/Akt kinase cascade, and cyclin-dependent kinase inhibitors.

Quercetin is a polyphenolic flavonoid found in capers, red onions, apples, and the flower buds of Sophora japonica. Beyond its classical antioxidant properties, quercetin functions as a senolytic compound that exerts multi-target inhibitory effects across the SCAP network. By inhibiting the upstream PI3K/Akt survival axis and downregulating anti-apoptotic defenses, quercetin disrupts the signaling that protects senescent cells from intrinsic apoptosis. Deprived of these survival signals, senescent cells undergo programmed cell death.

Preclinical studies demonstrate that senolytic protocols utilizing quercetin - often combined with the tyrosine kinase inhibitor dasatinib - reduce senescent cell burden across multiple tissues. This targeted clearance lowers circulating SASP factors, attenuates tissue fibrosis, restores endothelial reactivity, and improves functional health span. By removing senescent cells, quercetin mitigates the primary driver of chronic, low-grade inflammaging.

Modulating the mTOR Pathway for Optimal Autophagy

The mechanistic Target of Rapamycin (mTOR) is an evolutionarily conserved serine/threonine protein kinase that coordinates cellular metabolism by balancing anabolic growth with catabolic recycling. Operating within two multiprotein complexes - mTORC1 and mTORC2 - the mTOR pathway integrates signals from amino acids, growth factors, and intracellular energy levels. In nutrient-rich environments, mTORC1 promotes protein synthesis, lipogenesis, and cellular growth, while suppressing catabolic breakdown. Conversely, nutrient scarcity downregulates mTORC1, activating autophagy.

Autophagy is an intracellular degradation system that packages damaged organelles, misfolded protein aggregates, and biological debris into double-membraned autophagosomes for lysosomal degradation and recycling. A specialized branch of this pathway, mitophagy, selectively targets and clears damaged mitochondria. In modern metabolic conditions characterized by continuous caloric intake, mTORC1 can remain persistently active. This persistent signaling suppresses autophagy, causing damaged organelles and toxic aggregates to accumulate within tissues.

Quercetin functions as a natural modulator of mTOR signaling. By inhibiting upstream PI3K/Akt signaling and activating intracellular energy sensors, quercetin attenuates overactive mTORC1, mimicking the metabolic effects of caloric restriction. This down-regulation relieves inhibition on the ULK1 autophagy initiation complex, stimulating both general autophagy and mitophagy. As autophagy proceeds, cells clear protein aggregates and eliminate damaged mitochondria, supporting cellular longevity and proteostasis.

Enhancing Absorption: Phytosomes and Dietary Fats

Despite the biological activities of quercetin identified in experimental models, its clinical translation has historically been limited by poor oral bioavailability. Raw quercetin aglycone is a crystalline, hydrophobic polyphenol with poor solubility in water and gastrointestinal fluids. When ingested in unformulated powder forms, quercetin molecules aggregate in the gut lumen, resisting dissolution and passive absorption. Consequently, the vast majority of an unformulated dose passes into the colon unabsorbed, where it undergoes microbial degradation without reaching meaningful systemic concentrations.

To address these pharmacokinetic limitations, advanced delivery systems such as phytosomes were engineered. A phytosome is a 100% food-grade molecular complex where individual polyphenolic molecules are bound to dietary phospholipids, typically sunflower-derived phosphatidylcholine. Unlike a classical liposome - which encapsulates water-soluble compounds inside an aqueous core enclosed by a lipid bilayer - a phytosome forms an amphiphilic complex at the molecular level.

The polar head of the phosphatidylcholine molecule forms hydrogen bonds with the hydroxyl groups of the quercetin molecule, while its lipophilic fatty acid tails extend outward. This structural arrangement shields the polar regions of the flavonoid, creating a lipid-compatible complex that integrates smoothly into the intestinal mucosa.

Pharmacokinetic Parameter Unformulated Quercetin (500 mg) Quercetin Phytosome (500 mg) Clinical Significance
Peak Plasma Concentration (C_max) 10.93 +- 2.22  ng/mL

[cite: 36]

223.10 +- 16.32 ng/mL

[cite: 36]

Approximately 20-fold higher peak circulating concentration.
Area Under the Curve (AUC_last) 4,774.93 +- 1,190.61  min . ng/mL

[cite: 36]

96,163.87 +- 9,291.31 min . ng/mL

[cite: 36]

Roughly 20-fold increase in total systemic biological exposure.
Time to Peak Concentration (T_max) 290.00 +- 31.19 min

[cite: 36]

202.50 +- 35.97 min

[cite: 36]

Faster intestinal absorption and systemic distribution.
Formulation Matrix Crystalline aglycone; high luminal aggregation. Phospholipid complex; enhanced membrane transit. Direct cellular entry via physiological lipid pathways.
Human pharmacokinetic trials demonstrate that quercetin phytosomes achieve up to 20-fold greater oral bioavailability compared to standard unformulated quercetin extracts. For standard, non-phytosome quercetin preparations, co-ingestion with dietary lipids provides an alternative method to enhance absorption. Ingesting fats stimulates the release of cholecystokinin, triggering biliary secretion and the formation of mixed micelles in the small intestine. These micelles solubilize hydrophobic quercetin molecules, facilitating their diffusion across the unstirred water layer of the enterocyte brush border.

The Importance of Methylation in Healthy Aging

Vitamin B-Complex and Choline as Essential Methyl Donors

Methylation is an essential biochemical process occurring billions of times each second across all human tissues. It involves the transfer of a single-carbon unit - a methyl group consisting of one carbon atom bound to three hydrogen atoms - (CH3) - from a donor molecule to diverse recipients, including DNA, RNA, structural proteins, neurotransmitters, and membrane phospholipids. This transfer of one-carbon units is coordinated by the methionine-homocysteine cycle, which sustains genetic stability, detoxification pathways, and cellular repair.

At the center of this pathway sits S-adenosylmethionine (SAM), the universal methyl donor in human biology. When a methyltransferase enzyme transfers a methyl group from SAM to an acceptor molecule, SAM is converted into S-adenosylhomocysteine (SAH). SAH functions as a potent competitive inhibitor of intracellular methyltransferases. To maintain functional methylation, SAH is rapidly hydrolyzed into homocysteine, a sulfur-containing amino acid that must be remethylated or cleared through transsulfuration.

Homocysteine clearance proceeds through two distinct remethylation pathways. The primary route operates across most tissues via the enzyme methionine synthase, which requires vitamin B12 in its active methylcobalamin form. Methionine synthase transfers a methyl group from 5-methyltetrahydrofolate (5-MTHF, the active form of folate) to homocysteine, regenerating methionine. The ongoing production of 5-MTHF depends on the enzyme methylenetetrahydrofolate reductase (MTHFR), which utilizes riboflavin (vitamin B2) as a cofactor.

Alternatively, excess homocysteine can be routed into the transsulfuration pathway by vitamin B6 (as pyridoxal-5'-phosphate) to synthesize cystathionine, cysteine, and ultimately the antioxidant glutathione.

A secondary remethylation pathway, active predominantly in hepatic and renal tissues, bypasses folate entirely. In this route, dietary choline is oxidized to betaine (trimethylglycine or TMG). The enzyme betaine-homocysteine S-methyltransferase (BHMT) then transfers a methyl group from betaine directly to homocysteine, yielding methionine and dimethylglycine.

When dietary intake of active B-vitamins or choline is insufficient, or when genetic variations like MTHFR polymorphisms reduce pathway flux, the methylation cycle slows. Homocysteine accumulates in circulation, promoting vascular and neurological inflammation, while SAM reserves decline, restricting cellular methylation capacity.

Understanding DNA Methylation and Epigenetic Health

Every somatic cell in an organism carries an identical genetic code. Cellular differentiation and tissue-specific functions are governed by the epigenome: a regulatory layer of chemical modifications that dictates gene expression without altering underlying DNA sequences. DNA methylation represents the primary and most stable epigenetic modification. In this process, DNA methyltransferase (DNMT) enzymes utilize methyl groups donated by SAM to add a methyl tag to cytosine bases adjacent to guanine residues, forming 5-methylcytosine within CpG dinucleotide sites.

Under physiological conditions, DNA methylation maintains genomic stability and coordinates transcription. Methylation of promoter regions condenses chromatin, repressing transposable elements and silencing genes inappropriate for a given cell type. Conversely, hypomethylated promoters maintain an open chromatin state, allowing transcription factors to bind and initiate gene expression.

During biological aging, this epigenetic landscape undergoes progressive dysregulation, a phenomenon termed "epigenetic drift". Aging cells experience global hypomethylation alongside focal hypermethylation of specific gene promoters. Global loss of methyl tags destabilizes the genome, activating retrotransposons and pro-inflammatory pathways. Simultaneously, hypermethylation at targeted promoter sites silences critical tumor suppressor genes and DNA repair complexes.

This systematic change in DNA methylation patterns is consistent across populations, allowing researchers to develop molecular "epigenetic clocks". Algorithms such as the Horvath clock, PhenoAge, and GrimAge quantify biological age by profiling the methylation status of specific CpG sites across the genome. These clocks assess whether individuals are aging faster or slower than their chronological years. Ensuring a steady supply of methyl donors and preventing unnecessary SAM depletion supports DNMT activity, maintaining epigenetic patterns and genomic stability.

How the Methylation Cycle Impacts Energy and Cognitive Focus

Beyond long-term epigenetic regulation, the methylation cycle directly modulates immediate biochemical processes that govern daily energy, neurotransmission, and cognitive focus. Compromised methylation capacity frequently manifests as cognitive slowing, executive fatigue, and reduced physical stamina.

A major consumer of methyl reserves is the endogenous synthesis of creatine. Approximately 40% of all SAM-derived methyl groups in the human body are utilized by guanidinoacetate N-methyltransferase (GAMT) in the liver to synthesize creatine. Creatine then translocates to the brain and skeletal muscle, where it is phosphorylated into phosphocreatine.

Phosphocreatine functions as a rapid energy buffer, donating a high-energy phosphate group to regenerate ADP into ATP in milliseconds during demanding physical or cognitive tasks. When methyl donor availability falls, endogenous creatine synthesis drops, depleting phosphocreatine reserves and increasing susceptibility to neuromuscular and cognitive fatigue.

Methylation is equally central to central nervous system architecture. SAM provides methyl groups to convert phosphatidylethanolamine into phosphatidylcholine, the predominant phospholipid comprising neuronal cell membranes and the myelin sheaths that insulate axons. Intact myelin preserves rapid action potential conduction throughout the nervous system.

Furthermore, free choline derived from this pathway is the direct precursor to acetylcholine, the neurotransmitter required for attention, working memory, and learning.

The methylation cycle also governs monoamine neurotransmitter metabolism. SAM is required for the synthesis of adrenaline (epinephrine) from noradrenaline, while catechol-O-methyltransferase (COMT) relies on SAM to degrade dopamine and norepinephrine within the prefrontal cortex. Sluggish methylation disrupts this balance, contributing to cognitive fatigue, mood variability, and impaired mental performance.

Building a Comprehensive Longevity Protocol

Synergizing NR, Quercetin, and Methylated B-Vitamins

Longevity supplementation often falters when single molecules are administered in isolation, ignoring interconnected metabolic pathways. Designing an effective cellular longevity protocol requires combining complementary mechanisms that reinforce one another while preventing secondary metabolic deficits. The combination of Nicotinamide Riboside, Quercetin Phytosome, and Methylated B-Vitamins illustrates this multi-target synergy.

This synergy is grounded in the direct biochemical intersection between the NAD+ salvage pathway and the methylation cycle. When high-dose NR is supplemented to boost systemic NAD+, sirtuins and PARP enzymes consume the newly synthesized cofactor, generating substantial quantities of free nicotinamide (NAM). This intracellular nicotinamide faces two primary metabolic fates: it can be recycled back into NAD+ through the NAMPT-dependent salvage loop, or it can be cleared via methylation.

When the influx of nicotinamide exceeds salvage recycling capacity, the excess is cleared to avoid feedback inhibition of sirtuin enzymes. To accomplish this, the enzyme nicotinamide N-methyltransferase (NNMT) transfers a methyl group from SAM directly onto nicotinamide, forming 1-methylnicotinamide (1-MNA/MNAM), which is subsequently excreted in urine.

Prolonged, high-dose precursor administration without nutritional methyl support can elevate NNMT flux, depleting intracellular SAM reserves. As methyl groups are consumed clearing nicotinamide, the cellular SAM-to-SAH ratio falls, which can elevate circulating homocysteine and reduce methyl availability for DNA methylation and neurotransmitter synthesis.

Co-administering a fully methylated B-complex alongside choline or betaine addresses this potential bottleneck. Providing active methyl donors (such as 5-MTHF, methylcobalamin, and betaine) maintains the one-carbon donor pool. Even during increased NNMT activity, SAM pools remain stable, protecting DNA methylation fidelity and maintaining homocysteine within safe parameters.

Quercetin reinforces this protocol through complementary mechanisms. By clearing senescent cells and reducing SASP-mediated inflammation, quercetin downregulates CD38, the primary enzyme responsible for age-related NAD+ degradation. Suppressing CD38 prevents unnecessary breakdown of newly synthesized NAD+, enhancing the efficiency of NR supplementation.

Furthermore, while NR provides the NAD+ necessary to activate SIRT1-driven mitochondrial biogenesis, quercetin concurrently modulates mTORC1 to stimulate autophagy. This coordinated action ensures that newly generated mitochondria operate in an environment cleared of proteotoxic cellular debris.

The Crucial Role of Magnesium Glycinate and Zinc in Cellular Function

Longevity protocols require essential mineral cofactors to function efficiently. Without adequate divalent minerals acting as enzymatic cofactors and structural stabilizers, metabolic longevity pathways cannot operate at full capacity. Among these, magnesium and zinc are required for cellular repair, genomic stability, and energy production.

Magnesium serves as an obligatory cofactor in over 300 enzymatic reactions, primarily through its interaction with ATP. In biological systems, ATP exists predominantly as a chelate with a divalent magnesium ion, forming biologically active Mg2+ -ATP.

Every enzymatic reaction that synthesizes, transfers, or consumes cellular energy - including the enzymes of the NAD+ salvage pathway (NRK and NMNAT) and DNA polymerases - strictly requires Mg2+ -ATP as its substrate. Magnesium deficiency impairs these phosphorylation reactions, reducing the cellular utilization of NAD+ precursors.

Additionally, magnesium is an essential cofactor for the enzymes that activate dietary B-vitamins into their active forms. Supplying magnesium as magnesium glycinate provides high gastrointestinal bioavailability, minimal laxative effect, and yields glycine to support inhibitory neurotransmission and restful sleep.

Zinc serves as a vital structural component for more than 3,000 human transcription factors and enzymatic proteins. Its most prominent structural role in longevity occurs within zinc-finger motifs. These are specialized protein conformations stabilized by a zinc ion coordinated to cysteine and histidine residues.

The DNA damage sensor PARP-1 utilizes three zinc-finger domains to identify, track, and physically bind to single- and double-strand DNA breaks. Without adequate intracellular zinc, PARP-1 cannot properly assemble or dock onto damaged chromosomes, impairing DNA repair and increasing genomic instability.

Zinc is also an obligatory structural component of copper/zinc superoxide dismutase (Cu/Zn-SOD or SOD1), the primary cytosolic antioxidant enzyme that dismutates superoxide radicals into hydrogen peroxide, protecting mitochondrial membranes and nuclear DNA from premature senescence.

Integrating Prebiotics (like Acacia and Inulin) for Gut-Derived Longevity Markers

A comprehensive cellular longevity framework must extend beyond somatic tissues to encompass the gut microbiome. The intestinal microbiome functions as a central regulator of systemic inflammatory tone, immune development, and metabolic signaling. Age-associated dysbiosis - characterized by the loss of beneficial commensals and an overgrowth of pathobionts - frequently leads to breakdown of the intestinal barrier.

The gut epithelium consists of a single-cell monolayer sealed by tight junction proteins, including zonula occludens-1 (ZO-1), occludin, and claudins. When this physical barrier is disrupted by poor dietary fiber intake or dysbiosis, gut permeability increases.

This allows lipopolysaccharide (LPS), a component of the outer membrane of Gram-negative bacteria, to enter the portal and systemic circulation. The resulting "metabolic endotoxemia" activates Toll-like receptor 4 (TLR4) on immune cells, inducing NF-kB and systemic pro-inflammatory cytokine production. This persistent gut-derived inflammation exacerbates the SASP, accelerates tissue senescence, upregulates CD38, and drains systemic NAD+ reserves.

Prebiotic Soluble Fiber Fermentation Kinetics Primary Physiological Benefits
Acacia Fiber (Gum Arabic) Slow, uniform fermentation throughout the distal colon. High digestive tolerance without sudden gas; sustained distal SCFA generation.
Inulin (Fructo-oligosaccharides) Rapid, targeted bifidogenic fermentation. Promotes Bifidobacteria; upregulates tight junctions; reduces LPS translocation.
Supplying non-digestible prebiotic soluble fibers, such as acacia fiber and inulin, directly targets this inflammatory cascade. Acacia and inulin resist enzymatic hydrolysis in the upper gastrointestinal tract, reaching the colon intact to nourish beneficial commensal microbes, particularly Bifidobacterium species and Faecalibacterium prausnitzii. Through saccharolytic fermentation, these bacteria convert prebiotic fibers into short-chain fatty acids (SCFAs): acetate, propionate, and butyrate.

These short-chain fatty acids, particularly butyrate, exert direct protective effects on systemic longevity. Butyrate provides the primary metabolic fuel for colonic epithelial cells, supplying more than 70% of their baseline energy needs and supporting mitochondrial function within colonocytes.

Furthermore, SCFAs upregulate the expression of epithelial tight junction proteins (ZO-1, occludin, and claudin-1), restoring intestinal barrier integrity and preventing the translocation of inflammatory LPS into systemic circulation.

Systemically absorbed butyrate also functions as an endogenous histone deacetylase (HDAC) inhibitor, suppressing pro-inflammatory gene expression and supporting regulatory T cell (T_reg) development. Reducing metabolic endotoxemia dampens systemic inflammation, protecting vascular function and preventing premature NAD+ depletion.

Conclusion: The Integrated Cellular Longevity Matrix

Cellular longevity is achieved not by addressing isolated biomarkers in isolation, but by systematically supporting interconnected biological pathways. As bioenergetic capacity declines, cellular senescence accelerates, epigenetic patterns degrade, and gut barrier integrity weakens. A comprehensive approach addresses these biological vulnerabilities simultaneously.
Protocol Component Primary Biological Target Primary Biochemical Mechanism Coordinated Longevity Outcome
Nicotinamide Riboside (NR) NAD+ salvage Pathway Phosphorylated by NRK1/2 to bypass rate-limiting NAMPT. Restores mitochondrial ATP, activates SIRT1/3, fuels PARP-1 DNA repair.
Quercetin (Phytosome Form) Senescent Cells & mTORC1 Disrupts anti-apoptotic SCAP networks and suppresses PI3K/Akt/mTOR. Clears zombie cells, blunts toxic SASP, and triggers autophagic cleanup.
Methylated B-Complex & Choline/TMG One-Carbon Methylation Cycle Supplies methyl groups to regenerate SAM and clear homocysteine. Offsets NNMT clearance demands, protects DNA methylation, and fuels creatine.
Magnesium Glycinate & Zinc Enzymatic Cofactors & DNA Binding Forms active Mg2+ -ATP; stabilizes zinc-finger repair motifs. Ensures optimal ATP function, powers salvage kinases, supports PARP-1 docking.
Prebiotic Fibers (Acacia & Inulin) Gut Microbiome & Intestinal Wall Fermented into SCFAs (butyrate) via beneficial commensals. Seals intestinal tight junctions, halts LPS endotoxemia, lowers inflammaging.
Integrating these interventions creates clear biological synergy. Nicotinamide Riboside raises intracellular NAD+, providing the substrate for sirtuin-mediated mitochondrial biogenesis and PARP-1-mediated DNA repair.

Quercetin Phytosome clears senescent cells and modulates mTORC1, stimulating autophagy while dampening the inflammatory SASP cascade that accelerates CD38-mediated NAD+ destruction.

Methylated B-vitamins, active folate, and choline replenish SAM reserves, balancing the methyl requirements of NNMT-mediated nicotinamide clearance, preserving epigenetic DNA methylation, and maintaining neurotransmitter production.

Magnesium glycinate and zinc provide the structural and catalytic foundation required for ATP utilization, B-vitamin activation, and PARP-1 zinc-finger DNA repair docking.

Finally, prebiotic fibers generate short-chain fatty acids like butyrate, reinforcing the intestinal barrier and preventing metabolic endotoxemia from fueling systemic inflammation.

By coordinating energy replenishment, cellular waste clearance, epigenetic maintenance, and the suppression of systemic inflammation, this unified approach directly addresses the underlying drivers of cellular aging to support long-term physiological vitality.

--
Content Put together by Darrell Miller CEO of VitaNet LLC

(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=6650)


Is NAD+ the "Missing Link" in Modern Longevity Science?
TopPreviousNext

Date: April 11, 2026 12:24 PM
Author: Darrell Miller (support@vitanetonline.com)
Subject: Is NAD+ the "Missing Link" in Modern Longevity Science?


Nicotinamide Mononucleotide (NMN) is a naturally occurring molecule that serves as a direct precursor to Nicotinamide Adenine Dinucleotide (NAD+). As we age, our natural levels of NAD+ decline significantly—by age 50, most people have roughly half the levels they had in their youth. This decline is linked to many of the physiological hallmarks of aging.

How NMN Boosts NAD+ Levels

NMN is essentially a "building block" for NAD+. The process by which the body converts NMN into NAD+ is relatively direct, making it an efficient supplement for raising levels.
  1. Absorption: When NMN is ingested, it is rapidly absorbed from the gut into the bloodstream. Recent research suggests that a specific transporter (Slc12a8) allows NMN to enter cells directly.
  2. Conversion: Once inside the cell, an enzyme called nicotinamide mononucleotide adenylyltransferase (NMNAT) converts NMN into NAD+.
  3. The salvage Pathway: The body also uses a "recycling" system called the salvage pathway. After NAD+ is used by enzymes, it breaks down into nicotinamide (NAM), which is then converted back into NMN and eventually NAD+ again. Adding supplemental NMN provides the system with more raw material to complete this cycle.

Why Boost NAD+? The Biological Benefits

NAD+ is a "coenzyme" found in every single living cell. It is required for over 500 different enzymatic reactions. Here are the primary reasons why maintaining high NAD+ levels is critical for health:

1. Cellular Energy Production (ATP)

NAD+ plays a starring role in the mitochondria, the powerhouses of the cell. It acts as an electron carrier in the process of turning nutrients from food into ATP (Adenosine Triphosphate), which is the primary energy currency of the body. Without enough NAD+, cellular energy production falters, leading to fatigue and decreased metabolic function.

2. DNA Repair and Stability

Our DNA is constantly under attack from UV radiation, pollutants, and metabolic byproducts. To fix this, the body uses enzymes called PARPs (Poly ADP-Ribose Polymerases). These enzymes are strictly "NAD+-dependent," meaning they cannot function without consuming NAD+. By boosting NAD+, you provide the fuel necessary for cells to repair genetic damage effectively.

3. Activation of Sirtuins (The "Longevity Genes")

Sirtuins are a family of proteins responsible for cellular health, aging, and DNA protection. They are often called "guardians of the genome."
  • Sirtuins can only function in the presence of NAD+.
  • They help regulate inflammation, protect cells from oxidative stress, and manage how the body responds to fasting and exercise.
  • Low NAD+ levels mean sirtuins remain "dormant," potentially accelerating the aging process.

4. Metabolic Health and Insulin Sensitivity

Research indicates that increasing NAD+ through NMN can improve glucose metabolism and insulin sensitivity. This is particularly relevant for maintaining a healthy weight and reducing the risk of age-related metabolic disorders.

5. Circadian Rhythm Regulation

NAD+ levels fluctuate throughout the day and help regulate the body’s internal clock (the circadian rhythm). Maintaining healthy levels helps ensure that your cells know when to be active and when to undergo repair, which can improve sleep quality and daytime alertness.

Note: While NMN is widely studied in animal models with promising results regarding lifespan and healthspan, human clinical trials are ongoing to fully confirm long-term efficacy and optimal dosage. Always consult a healthcare professional before starting new supplements.

Furthermore:

While the basics of NMN and NAD+ focus on energy and aging, there is a much deeper layer to this "master molecule" that involves cellular theft, "zombie" cells, and the critical importance of a process called methylation.

Here are the vital pieces of the NAD+ puzzle that aren't usually mentioned:

1. The "NAD+ Thieves": CD38 and Inflammation

Boosting NAD+ with NMN is only half the battle; the other half is stopping the "thieves" that steal it.
  • CD38: This is an enzyme that acts as a massive "sink" for NAD+. As we age, our bodies produce more CD38, especially in response to chronic low-grade inflammation. CD38 is incredibly "greedy" - it can destroy up to 100 molecules of NAD+ for every one it processes.
  • Senescent ("Zombie") Cells: These are old cells that refuse to die. They secrete a cocktail of inflammatory proteins (called SASP) that trigger CD38 across the body. This is why NAD+ levels drop so sharply - it’s not just that we produce less; it's that we are destroying it faster than ever.

2. The Methylation Connection (Why you need TMG)

This is perhaps the most important practical detail for anyone taking NMN.
  • When your body uses NMN to make NAD+, it eventually breaks the NAD+ down into a byproduct called Nicotinamide (NAM).
  • To get rid of excess NAM, your liver has to "tag" it with a methyl group so it can be excreted in urine.
  • If you take high doses of NMN without replenishing these methyl groups, you can deplete your "methyl pool." This can lead to fatigue, low mood, or high levels of homocysteine (a risk factor for heart disease).
  • The Solution: Many people take TMG (Trimethylglycine) alongside NMN to provide the body with extra methyl groups and keep the system balanced.

3. The "Double-Edged Sword" of Cancer

NAD+ is essential for all living cells, including cancer cells.
  • Prevention: High NAD+ levels help repair DNA, which prevents the mutations that cause cancer.
  • Fuel: However, recent research (including studies from early 2026) suggests that if a tumor already exists, boosting NAD+ might inadvertently provide the "fuel" the tumor needs to grow or resist chemotherapy.
  • Takeaway: While NAD+ is generally considered safe for healthy individuals, medical experts advise caution and specialist supervision for those with an active cancer diagnosis.

4. Regulatory Status (The 2026 Update)

The legal status of NMN has been a rollercoaster. In late 2022, the FDA initially ruled that NMN could not be marketed as a supplement because it was being investigated as a drug. However, as of late 2025, the FDA issued updated guidance essentially reinstating NMN’s status as a legal dietary ingredient, clearing the way for its continued sale in the U.S.

5. Natural Boosters and "Sirtuin Activators"

Supplementing NMN is just one way to boost the system. You can also:
  • Inhibit CD38: Flavonoids like Apigenin (found in parsley/chamomile) and Quercetin act as natural CD38 inhibitors, effectively "plugging the leak" in your NAD+ tank.
  • The NAD+/NADH Ratio: It isn't just about the total amount of NAD+; it's about the ratio of NAD+ (oxidized) to NADH (reduced). High-intensity interval training (HIIT) and fasting are the most effective ways to naturally "flip" NADH back into the beneficial NAD+ form.
Ultimately, the science of NMN and NAD+ represents a shift from merely treating symptoms of aging to supporting the body’s fundamental cellular machinery. By replenishing the "master molecule" and addressing the "thieves" that drain it, we can effectively fuel DNA repair, boost mitochondrial energy, and activate the longevity-linked sirtuins. However, as we have seen with the necessity of TMG for methylation and the evolving research of 2026, boosting NAD+ is not a "set it and forget it" solution - it is a balancing act. Approaching NMN as one part of a holistic strategy - alongside proper nutrition, exercise, and targeted co-factors—is the most effective way to ensure your cells remain resilient and energized for the long haul.

Are you planning to focus your blog post on the anti-aging benefits for a general audience, or would you like to lean more into the technical "biohacking" side of science?

(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=6636)


How calcium can Help Prevent Bone Loss
TopPreviousNext

Date: November 08, 2013 09:59 AM
Author: Darrell Miller (dm@vitanetonline.com)
Subject: How calcium can Help Prevent Bone Loss

calciumWhat is bone loss?

Bones are always in a flux. Since it's living tissue, old bone is absorbed, and new bone is built up. This process is referred to as remodeling. Bone loss occurs when there is absorption of more bone than is being built up.

What causes it?

Bone loss is a natural process that comes with age. There are factors that are beyond human control like genetics, sex, and ethnicity, that contribute to loss of bone. However, some lifestyle factors that can be controlled for instance, being physically inactive, low hormone levels, that is, estrogen in females, and testosterone in males, habits like smoking and drinking alcohol do contribute to faster loss of bone.

When you are intoxicated, you risk falling and breaking a bone. Alcohol cases loss of magnesium via urine. Smokers generally have weaker bones. Female smokers are even at a higher risk of bone fractures after menopause. They also begin their menopause early due to reduced estrogen levels. Both male and female smokers are thinner, thus tend to have less bone mass and take longer to heal in case of fractures.

How to salvage the situation

The best way to prevent bone loss is by ensuring that you develop very strong bones during the first 30 years of your life and then minimize their loss in adulthood. This is how to go about it:

Ensure that you intake vitamin D in your diet, expose yourself to early morning or evening sunlight, and take supplements if need be. Vitamin D is very helpful when calcium levels are low in the body. It is converted to its active form reducing loss of calcium via urine in the kidney, and increasing its absorption in the small intestine.

Intake a lot of calcium too, as there are two sources of calcium in your body: via your diet and from your bones. It is the latter that is dangerous. Your body will absorb calcium from the bones if there isn't enough in the body. This calcium is really difficult to replace.

Intake a diet with magnesium too. It helps in absorption of calcium. If there is excess calcium in the body, one could suffer from arthritis as it will collect in the soft tissues.

References:
  1. //www.hsph.harvard.edu/nutritionsource/calcium-full-story/#bone-loss
  2. //www.niams.nih.gov/Health_Info/Bone/Osteoporosis/osteoporosis_ff.asp
  3. //www.nlm.nih.gov/medlineplus/ency/patientinstructions/000506.htm

(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=2884)


D-Ribose Powder Benefits!
TopPreviousNext

Date: April 10, 2007 11:57 AM
Author: Darrell Miller (dm@vitanetonline.com)
Subject: D-Ribose Powder Benefits!

Benefits

Supports normal heart function*

A significant amount of in vitro, animal and human research suggests benefits of ribose on heart function.* Studies have shown that ribose supplementation can enhance cardiac energy levels and support cardiovascular metabolism.* Ribose has been shown in clinical trials to enhance the recovery of heart muscle ATP levels and improve myocardial function following exercise.

Studies suggest that ribose supplementation can increase the tolerability of the cardiovascular system to exercise-induced fatigue.1 In one study, twenty men underwent treadmill exercise tests on two consecutive days to confirm the onset of fatigue secondary to exercise. The participants were then randomized to the treatment group or a placebo group. The groups received either four doses of 15 grams of D-ribose (60 grams/day total) or the same amount of placebo each day. After three days of treatment, another treadmill test was performed. The time it took to reach the specified level of fatigue was significantly greater in the ribose group than in the placebo group.

Another study investigated the ability of ribose to support healthy heart function and quality of life.2 In a randomized, crossover design study, fifteen individuals were given 5 grams three times a day of either D-ribose or placebo. Each treatment period lasted three weeks. In patients receiving ribose, echocardiography demonstrated enhancement of heart function, reflecting a “more efficient relaxation phase of the heart”. Participants also had a significant improvement in their subjective quality of life scores compared to placebo.  

Scientists suggest that suboptimal heart function is a result of the heart requiring more energy to function properly. Ribose supports the heart’s enhanced energy requirements, promoting optimal heart function. It does so by enhancing the stores of high-energy phosphates in heart tissue. These intermediates are necessary for the production and resynthesis of ATP. A double-blind crossover study in which 12 individuals were randomized to receive either ribose or dextrose (both administered as 5 grams three times daily for three weeks, followed by a 1-week washout period and crossover of treatments for three additional weeks) suggested significant enhancements in normal cardiac function during the period of ribose supplementation.3

Perhaps one of the more useful illustrations of the potential for ribose to support heart function comes from a study in which 20 rats received a continuous infusion of ribose for 24 hours (control rats received an infusion of saline). The hearts were then explanted (as they would be for heart transplants) and placed in preservation solution that was enriched with ribose for 4 hours. ATP levels were measured from tissue biopsies and revealed that 10 of the ribose-treated hearts had ATP levels higher than 12.3 micromoles per gram whereas saline-treated hearts (controls) had lower ATP levels, with 20% showing levels below 10 micromoles per gram of tissue. This provides support for the hypothesis that ribose may enhance the preservation of ATP levels in cardiac tissue, promoting normal heart function.4

Further animal studies have shown that ribose significantly enhances heart function after experimentally induced cardiac depression. Rats were injected with isoproterenol (a drug that stimulates sympathetic nervous system function) and had their abdominal aorta constricted to induce depression of heart function and reduce cardiac ATP levels. The decrease in ATP was primarily responsible for the depression of heart function. Continuous infusion of ribose for 24 hours replenished ATP concentrations to normal levels and normalized heart function in these animals.5

Ribose may strengthen and support the body’s crucial antioxidant defenses*

Ribose may support the body’s innate antioxidant mechanisms while promoting an antioxidant effect of its own. Intense exercise and other strenuous activity can induce the production of free radicals. Preliminary studies suggest that ribose can attenuate some of the effects of oxidation seen after performance of intensive exercise.

One small human study indicated that ribose administered at a dose of seven grams before and after a bout of cycling exercise may reduce free radical production.6 Seven volunteers ingested either ribose or placebo both before and after intense exercise. Markers of lipid peroxidation, including malondialdehyde, significantly decreased in the ribose-supplemented group, while increasing in the control group. The results of this study indicate a possible effect of ribose in supporting antioxidant activity.

Supports healthy energy levels in heart and muscle tissue*

After bouts of intense exercise, ATP levels have been shown to decrease by an average of 15 to 20%.7 The amount of ATP stored in the muscle is limited and so the body must have the potential to rebuild ATP stores. ATP is the fuel necessary for the integrity and function of a cell. In addition, several studies have found correlations between ATP content and heart function.1 Research that was also alluded to above suggests that ribose stimulates ATP synthesis and supports heart and muscle function by enhancing ATP levels in cardiac and muscle tissue. D-ribose is an essential building block for the synthesis of ATP through the pentose phosphate pathway. 

The results of ribose supplementation enhancing ATP levels in muscle are evidenced by studies suggesting beneficial effects on anaerobic performance. In a randomized, placebo-controlled crossover study assessing the effects of acute ribose supplementation, participants receiving the ribose supplement had increases in mean power (a measure of average overall muscular strength output during the sprint) and peak power (a measure of the highest muscular strength output during the sprint) when undergoing a series of cycle sprints.8 While this effect was not noted in all of the six short cycling sprints that the participants underwent, the study does illustrate the potential benefits of ribose on ATP production and, secondarily, on enhancing exercise performance.

A second placebo-controlled trial investigated the effects of four weeks of ribose-supplementation (10 grams /day) on male bodybuilders. Of the 20 participants who were recruited, twelve completed the study. Each subject participated in a heavy-resistance training program designed to increase skeletal muscle mass. The effects of ribose on body composition (body weight, body fat, lean body mass, fat mass, and bone mineral content) were also assessed. The results suggested that ribose increased total work capacity and bench press strength compared to placebo, without altering body composition.9

Supports energy recovery after exercise*

Animal studies have suggested that the administration of ribose after exercise increases the rate of adenine salvage by five to seven-fold in muscle tissue7, supporting energy recovery after exercise. When ATP is utilized by muscle tissue, the degradation products include adenine nucleotides (Adenine is one of two purine bases that is a component of DNA). Adenine is recycled to synthesize DNA, and the salvage of adenine within the muscle tissue is crucial to energy recovery. Studies have shown that the presence of adequate ribose concentrations is the rate-limiting step in the purine salvage pathway. Therefore, increased adenine salvage could potentially help in the recovery and regeneration of ATP after intense bouts of activity.

A study investigated the effect of oral intake of ribose on the synthesis of AMP, a precursor to ATP.10 Participants performed intense cycle training for seven days. They then received either ribose (at a concentration of 200 mg/kg body weight, which is equivalent to 14 grams per day for an average 70 kilogram male) or placebo three times a day for the following three days. Exercise tests were performed again on day 4. Muscle biopsy samples were taken before the first training session, immediately after, and again five hours, 24 hours, and 72 hours after the last training session. No differences were seen in exercise performance between the groups. The intense exercise caused the ATP levels in muscle to decrease in both groups. However, at 72 hours post-exercise, the ribose group exhibited a much higher ATP level than the placebo group. The muscle levels of critical building blocks for ATP, including total adenine nucleotides (TAN) and inosine 5’-monophosphate (IMP), were also significantly higher in the ribose group compared to the placebo group at 24 hours after exercise. Ribose-supplementation was shown to enhance the resynthesis of ATP after intense exercise.

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Safety

Caution: Insulin-dependent diabetics and pregnant women should consult their physician before use.

Suggested Adult Use: Take 1 or 2 scoops mixed in water, juice or other beverage two times per day. May be taken with or without food.

Scientific References

1) Pliml, W., von Arnim, T., Stablein, A., Hofmann, H., Zimmer, H., Erdmann, E. Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. The Lancet. 1992;340:507-510.

2) Omran, H., Illien, S., MacCarter, D., St. Cyr, J.A., Luderitz, B. D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. The European Journal of Heart Failure. 2003;5:615-619.

3) Illien, S., Omran, H., MacCarter, D., St. Cyr, J.A. Ribose improves myocardial function in congestive heart failure. FASEB Journal 2001;15(5): A1142

 

4) Muller C., Zimmer H., Gross M., Gresser U., Brotsack I., Wehling M., Pliml W. Effect of ribose on cardiac adenine nucleotides in a donor model for heart transplantation. Eur J Med Res. 1998 Dec 16;3(12):554-8.

5) Zimmer H.G. Normalization of depressed heart function in rats by ribose. Science. 1983 Apr 1;220(4592):81-2.

6) Seifert, J.G., Subudhi, A., Fu, M., Riska, J.J. The effects of ribose ingestion on indices of free radical production during hypoxic exercise. Free Rad Biol Med 2002; 33(Suppl 1) S269.

7) Zarzeczny, R., Brault, J.J., Abraham, K.A., Hancock, C.R., Terjung, R. Influence of ribose on adenine salvage after intense muscle contractions. J Applied Physiology. 2001;91:1775-1781. 

8) Berardi J.M., Ziegenfuss T.N. Effects of ribose supplementation on repeated sprint performance in men. J Strength Cond Res. 2003 Feb;17(1):47-52.

9) Van Gammeren, D.V., Falk, D., Antonio, J. The effects of four weeks of ribose supplementation on body composition and exercise performance in healthy, young, male recreational bodybuilders: a double-blind, placebo-controlled trial. Current Ther Research. 2002;63(8):486-495.

10) Hellsten, Y., Skadhauge, L., Bangsbo, J. Effect of ribose supplementation on resynthesis of adenine nucleotides after intense intermittent training in humans. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology. 2004;286:R182-R188.



--
Buy Ribose at Vitanet at a Discount

(https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=1510)


NOW is the leader in quality and value
TopPreviousNext

Date: October 21, 2005 08:12 AM
Author: Darrell Miller (dm@vitanetonline.com)
Subject: NOW is the leader in quality and value

NOW is the leader in quality and value

  • • NOW will often have the lowest price, and our quality and value is second to none.
  • • NOW offers specials every month granting retailers the opportunity to showcase extremely competitive products in many of the most popular categories.
  • • Compare our price on trademarked ingredients such as ester-c, 7-keto, Carnipure, Phase-2 and Relora to see how much money NOW can save you.

    “We only deal with companies that support the natural products industry and have a strong public service mission”

    We couldn’t agree more. NOW has, and will continue to fight for the rights of consumers to take safe supplements. As one of the most active and influential advocates in the natural products industry, we proudly support the following industry organizations.

    NFA, Citizens for health, AHPA, OTA, The Herb Research Foundation, The American Botanical Council, Consumers for Health Choice (UK), The GMO Task Force, The GMP Task Force, American Herbal Pharmacopoeia, The Campaign to label Genetically Engineered Foods, AOAC (method validation), AOCS (American Oil Chemist Society), The Dietary Supplement Education Alliance (DSEA), and More…

    “Does NOW support any Charitable or public services?”

    NOW is a leading recycling company and was awarded a silver medal for nutrition business journal in 2005 for our dedication to environmental and sustainability issues. We use environmental-friendly packaging and procedures to ensure that our impact on the environment is minimal. Here are just a few of the charities and originations NOW generously supports:

    Local Heal Clinics and food banks, salvation Army, Marklund children’s home, African meal-a-day fund, compassion international, vitamin angel, world relief, Indian orphanage, Hephzibah children’s home, nature conservancy, Americas second harvest, world wild life, and many more

    (https://vitanetonline.com:443/forums/Index.cfm?CFApp=1&Message_ID=858)



  • VitaNet ® LLC. Discount Vitamin Store.